Merck-partnered Janux hires CMO as its bispecifics near clinic

Janux Therapeutics has named Wayne Godfrey, M.D., as its chief medical officer. Godfrey joins the Merck-partnered T-cell engager startup as it gears up to take candidates against PSMA, EGFR and TROP2 into the clinic.